Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis

Figure 4

Results of tumor formation in nude mice after treatment in each group: (a) tumors isolated from each group of mice; (b) graph of tumor volume of nude mice in each group; (c) statistical results of tumor inhibition rate in each group.

(a)

(b)

(c)